Triose phosphate isomerase deficiency in 3 French families: two novel nullalleles, a frameshift mutation (TPI Alfortville) and an alteration in the initiation codon (TPI Paris)
C. Valentin et al., Triose phosphate isomerase deficiency in 3 French families: two novel nullalleles, a frameshift mutation (TPI Alfortville) and an alteration in the initiation codon (TPI Paris), BLOOD, 96(3), 2000, pp. 1130-1135
Three French families with triose phosphate isomerase (TPI) deficiency were
studied, and 2 new mutations giving rise to null alleles were observed: a
frameshift mutation with deletion of the 86-87 TG dinucleotide in codon 29
(TPI Alfortville) and a T-A transversion in nucleotide 2 of the initiation
codon (TPI Paris). The first mutation occurred in compound heterozygosity w
ith the frequent E105D mutation. The second mutation occurred in associatio
n with the 2-nucleotide promoter variant (-43G,-46A), In a third family, th
e propositus was an E105D homozygote. In the TPI Paris family, the coinheri
tance of the -43,-46 promoter variant appeared to exert little, if any, eff
ect on TPI enzyme activity, a finding consistent with 2 previous reports th
at questioned the putative role of the promoter polymorphism as a true defi
ciency variant. Similarly, the further coinheritance of glucose-6-phosphate
dehydrogenase (G6PD) A- (202 G-->A/376 A-->G) appeared to have little effe
ct on the observed phenotype, Compound heterozygosity for the E105D mutatio
n with the null allele TPI Alfortville appeared to lead to a more severe cl
inical syndrome than did E105D homozygosity, suggesting that compound heter
ozygosity with null alleles may lead to more profound clinical abnormalitie
s than homozygosity with missense alleles, A simple, rapid polymerase chain
reaction and restriction enzyme procedure for the E105D mutation was devel
oped for prenatal diagnosis in one family and subsequently used for screeni
ng in the other families. (C) 2000 by The American Society of HematoloEly